25 XP   0   0   10

Purapharm Corp Ltd
Buy, Hold or Sell?

Let's analyse Purapharm together

PenkeI guess you are interested in Purapharm Corp Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Purapharm Corp Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Purapharm Corp Ltd

I send you an email if I find something interesting about Purapharm Corp Ltd.

Quick analysis of Purapharm (30 sec.)










What can you expect buying and holding a share of Purapharm? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
HK$0.65
Expected worth in 1 year
HK$-0.80
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
HK$-1.45
Return On Investment
-195.6%

For what price can you sell your share?

Current Price per Share
HK$0.74
Expected price per share
HK$0.73 - HK$0.75
How sure are you?
50%

1. Valuation of Purapharm (5 min.)




Live pricePrice per Share (EOD)

HK$0.74

Intrinsic Value Per Share

HK$-0.17 - HK$2.87

Total Value Per Share

HK$0.48 - HK$3.52

2. Growth of Purapharm (5 min.)




Is Purapharm growing?

Current yearPrevious yearGrowGrow %
How rich?$32.9m$51.2m-$18.2m-55.5%

How much money is Purapharm making?

Current yearPrevious yearGrowGrow %
Making money-$15.3m-$15.5m$212.3k1.4%
Net Profit Margin-26.8%-18.5%--

How much money comes from the company's main activities?

3. Financial Health of Purapharm (5 min.)




What can you expect buying and holding a share of Purapharm? (5 min.)

Welcome investor! Purapharm's management wants to use your money to grow the business. In return you get a share of Purapharm.

What can you expect buying and holding a share of Purapharm?

First you should know what it really means to hold a share of Purapharm. And how you can make/lose money.

Speculation

The Price per Share of Purapharm is HK$0.74. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Purapharm.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Purapharm, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.65. Based on the TTM, the Book Value Change Per Share is HK$-0.36 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.28 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Purapharm.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.04-5.2%-0.04-5.2%-0.04-5.3%-0.03-3.6%-0.01-1.3%
Usd Book Value Change Per Share-0.05-6.2%-0.05-6.2%-0.04-4.8%-0.02-2.5%0.010.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.4%
Usd Total Gains Per Share-0.05-6.2%-0.05-6.2%-0.04-4.8%-0.02-2.5%0.011.3%
Usd Price Per Share0.16-0.16-0.10-0.16-0.22-
Price to Earnings Ratio-4.22--4.22--2.63-7.87-78.32-
Price-to-Total Gains Ratio-3.54--3.54--2.91-11.22-50.55-
Price to Book Ratio1.96-1.96-0.80-1.23-1.54-
Price-to-Total Gains Ratio-3.54--3.54--2.91-11.22-50.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.094498
Number of shares10582
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.05-0.02
Usd Total Gains Per Share-0.05-0.02
Gains per Quarter (10582 shares)-489.02-198.51
Gains per Year (10582 shares)-1,956.09-794.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1956-19660-794-804
20-3912-39220-1588-1598
30-5868-58780-2382-2392
40-7824-78340-3176-3186
50-9780-97900-3970-3980
60-11737-117460-4764-4774
70-13693-137020-5558-5568
80-15649-156580-6352-6362
90-17605-176140-7146-7156
100-19561-195700-7941-7950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%7.03.01.063.6%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%7.04.00.063.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%5.00.05.050.0%5.00.06.045.5%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%8.03.00.072.7%

Fundamentals of Purapharm

About Purapharm Corp Ltd

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Oncozac, Haveron, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services, and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.

Fundamental data was last updated by Penke on 2024-04-15 22:51:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Purapharm Corp Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Purapharm earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Purapharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -26.8% means that $-0.27 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Purapharm Corp Ltd:

  • The MRQ is -26.8%. The company is making a huge loss. -2
  • The TTM is -26.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-26.8%TTM-26.8%0.0%
TTM-26.8%YOY-18.5%-8.4%
TTM-26.8%5Y-14.0%-12.8%
5Y-14.0%10Y-4.1%-9.9%
1.1.2. Return on Assets

Shows how efficient Purapharm is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Purapharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • -11.8% Return on Assets means that Purapharm generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Purapharm Corp Ltd:

  • The MRQ is -11.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.8%TTM-11.8%0.0%
TTM-11.8%YOY-10.1%-1.7%
TTM-11.8%5Y-7.3%-4.5%
5Y-7.3%10Y-1.3%-6.0%
1.1.3. Return on Equity

Shows how efficient Purapharm is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Purapharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • -46.5% Return on Equity means Purapharm generated $-0.47 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Purapharm Corp Ltd:

  • The MRQ is -46.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -46.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-46.5%TTM-46.5%0.0%
TTM-46.5%YOY-30.4%-16.2%
TTM-46.5%5Y-26.0%-20.6%
5Y-26.0%10Y-5.5%-20.5%

1.2. Operating Efficiency of Purapharm Corp Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Purapharm is operating .

  • Measures how much profit Purapharm makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Purapharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -21.4% means the company generated $-0.21  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Purapharm Corp Ltd:

  • The MRQ is -21.4%. The company is operating very inefficient. -2
  • The TTM is -21.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-21.4%TTM-21.4%0.0%
TTM-21.4%YOY2.3%-23.7%
TTM-21.4%5Y-2.0%-19.4%
5Y-2.0%10Y3.7%-5.7%
1.2.2. Operating Ratio

Measures how efficient Purapharm is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.51 means that the operating costs are $1.51 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Purapharm Corp Ltd:

  • The MRQ is 1.513. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.513. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.513TTM1.5130.000
TTM1.513YOY1.293+0.220
TTM1.5135Y1.220+0.292
5Y1.22010Y1.095+0.125

1.3. Liquidity of Purapharm Corp Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Purapharm is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.73 means the company has $0.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Purapharm Corp Ltd:

  • The MRQ is 0.730. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.730. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.730TTM0.7300.000
TTM0.730YOY0.918-0.188
TTM0.7305Y0.966-0.235
5Y0.96610Y1.185-0.219
1.3.2. Quick Ratio

Measures if Purapharm is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Purapharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.25 means the company can pay off $0.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Purapharm Corp Ltd:

  • The MRQ is 0.246. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.246. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.246TTM0.2460.000
TTM0.246YOY0.495-0.249
TTM0.2465Y0.490-0.244
5Y0.49010Y0.684-0.194

1.4. Solvency of Purapharm Corp Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Purapharm assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Purapharm to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.75 means that Purapharm assets are financed with 74.6% credit (debt) and the remaining percentage (100% - 74.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Purapharm Corp Ltd:

  • The MRQ is 0.746. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.746. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.746TTM0.7460.000
TTM0.746YOY0.667+0.079
TTM0.7465Y0.665+0.081
5Y0.66510Y0.616+0.048
1.4.2. Debt to Equity Ratio

Measures if Purapharm is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Purapharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 293.6% means that company has $2.94 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Purapharm Corp Ltd:

  • The MRQ is 2.936. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.936. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.936TTM2.9360.000
TTM2.936YOY2.003+0.933
TTM2.9365Y2.074+0.861
5Y2.07410Y1.897+0.178

2. Market Valuation of Purapharm Corp Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Purapharm generates.

  • Above 15 is considered overpriced but always compare Purapharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -4.22 means the investor is paying $-4.22 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Purapharm Corp Ltd:

  • The EOD is -2.437. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.215. Based on the earnings, the company is expensive. -2
  • The TTM is -4.215. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.437MRQ-4.215+1.778
MRQ-4.215TTM-4.2150.000
TTM-4.215YOY-2.631-1.584
TTM-4.2155Y7.874-12.090
5Y7.87410Y78.324-70.450
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Purapharm Corp Ltd:

  • The EOD is 4.511. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.802. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.802. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.511MRQ7.802-3.292
MRQ7.802TTM7.8020.000
TTM7.802YOY-15.213+23.016
TTM7.8025Y9.693-1.890
5Y9.69310Y-0.968+10.661
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Purapharm is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Purapharm Corp Ltd:

  • The EOD is 1.134. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.962. Based on the equity, the company is underpriced. +1
  • The TTM is 1.962. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.134MRQ1.962-0.828
MRQ1.962TTM1.9620.000
TTM1.962YOY0.799+1.163
TTM1.9625Y1.233+0.729
5Y1.23310Y1.544-0.311
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Purapharm Corp Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.362-0.3620%-0.278-23%-0.147-59%0.054-769%
Book Value Per Share--0.6520.6520%1.014-36%1.059-38%0.954-32%
Current Ratio--0.7300.7300%0.918-20%0.966-24%1.185-38%
Debt To Asset Ratio--0.7460.7460%0.667+12%0.665+12%0.616+21%
Debt To Equity Ratio--2.9362.9360%2.003+47%2.074+42%1.897+55%
Dividend Per Share----0%-0%-0%0.021-100%
Eps---0.304-0.3040%-0.308+1%-0.211-31%-0.074-76%
Free Cash Flow Per Share--0.1640.1640%-0.053+132%0.071+132%-0.044+127%
Free Cash Flow To Equity Per Share--0.0740.0740%-0.094+226%-0.012+116%0.060+23%
Gross Profit Margin--1.0001.0000%1.0000%-2.340+334%-12.081+1308%
Intrinsic Value_10Y_max--2.865--------
Intrinsic Value_10Y_min---0.175--------
Intrinsic Value_1Y_max--0.118--------
Intrinsic Value_1Y_min---0.038--------
Intrinsic Value_3Y_max--0.482--------
Intrinsic Value_3Y_min---0.097--------
Intrinsic Value_5Y_max--1.003--------
Intrinsic Value_5Y_min---0.137--------
Market Cap292963774.080-73%506748512.000506748512.0000%320676563.520+58%486953372.608+4%691236184.256-27%
Net Profit Margin---0.268-0.2680%-0.185-31%-0.140-48%-0.041-85%
Operating Margin---0.214-0.2140%0.023-1034%-0.020-90%0.037-680%
Operating Ratio--1.5131.5130%1.293+17%1.220+24%1.095+38%
Pb Ratio1.134-73%1.9621.9620%0.799+146%1.233+59%1.544+27%
Pe Ratio-2.437+42%-4.215-4.2150%-2.631-38%7.874-154%78.324-105%
Price Per Share0.740-73%1.2801.2800%0.810+58%1.230+4%1.746-27%
Price To Free Cash Flow Ratio4.511-73%7.8027.8020%-15.213+295%9.693-20%-0.968+112%
Price To Total Gains Ratio-2.045+42%-3.537-3.5370%-2.913-18%11.221-132%50.546-107%
Quick Ratio--0.2460.2460%0.495-50%0.490-50%0.684-64%
Return On Assets---0.118-0.1180%-0.101-15%-0.073-38%-0.013-89%
Return On Equity---0.465-0.4650%-0.304-35%-0.260-44%-0.055-88%
Total Gains Per Share---0.362-0.3620%-0.278-23%-0.147-59%0.076-579%
Usd Book Value--32983505.30032983505.3000%51278956.600-36%53527932.380-38%48245941.130-32%
Usd Book Value Change Per Share---0.046-0.0460%-0.036-23%-0.019-59%0.007-769%
Usd Book Value Per Share--0.0830.0830%0.130-36%0.135-38%0.122-32%
Usd Dividend Per Share----0%-0%-0%0.003-100%
Usd Eps---0.039-0.0390%-0.039+1%-0.027-31%-0.009-76%
Usd Free Cash Flow--8293731.9008293731.9000%-2691788.300+132%3568295.560+132%-2243459.140+127%
Usd Free Cash Flow Per Share--0.0210.0210%-0.007+132%0.009+132%-0.006+127%
Usd Free Cash Flow To Equity Per Share--0.0090.0090%-0.012+226%-0.001+116%0.008+23%
Usd Market Cap37411473.950-73%64711784.98264711784.9820%40950397.162+58%62183945.682+4%88270860.729-27%
Usd Price Per Share0.094-73%0.1630.1630%0.103+58%0.157+4%0.223-27%
Usd Profit---15351327.800-15351327.8000%-15563692.900+1%-10645914.820-31%-3749233.690-76%
Usd Revenue--57218411.30057218411.3000%84229898.400-32%80472913.320-29%69736523.050-18%
Usd Total Gains Per Share---0.046-0.0460%-0.036-23%-0.019-59%0.010-579%
 EOD+4 -4MRQTTM+0 -0YOY+12 -215Y+11 -2310Y+8 -28

3.2. Fundamental Score

Let's check the fundamental score of Purapharm Corp Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.437
Price to Book Ratio (EOD)Between0-11.134
Net Profit Margin (MRQ)Greater than0-0.268
Operating Margin (MRQ)Greater than0-0.214
Quick Ratio (MRQ)Greater than10.246
Current Ratio (MRQ)Greater than10.730
Debt to Asset Ratio (MRQ)Less than10.746
Debt to Equity Ratio (MRQ)Less than12.936
Return on Equity (MRQ)Greater than0.15-0.465
Return on Assets (MRQ)Greater than0.05-0.118
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Purapharm Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.777
Ma 20Greater thanMa 500.790
Ma 50Greater thanMa 1000.802
Ma 100Greater thanMa 2000.846
OpenGreater thanClose0.750
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in HKD. All numbers in thousands.

Summary
Total Assets1,016,497
Total Liabilities758,208
Total Stockholder Equity258,289
 As reported
Total Liabilities 758,208
Total Stockholder Equity+ 258,289
Total Assets = 1,016,497

Assets

Total Assets1,016,497
Total Current Assets485,996
Long-term Assets530,501
Total Current Assets
Cash And Cash Equivalents 75,831
Net Receivables 163,811
Inventory 190,812
Other Current Assets 31,183
Total Current Assets  (as reported)485,996
Total Current Assets  (calculated)461,637
+/- 24,359
Long-term Assets
Property Plant Equipment 431,077
Goodwill 20,993
Intangible Assets 37,640
Other Assets 20,851
Long-term Assets  (as reported)530,501
Long-term Assets  (calculated)510,561
+/- 19,940

Liabilities & Shareholders' Equity

Total Current Liabilities665,406
Long-term Liabilities92,802
Total Stockholder Equity258,289
Total Current Liabilities
Short Long Term Debt 410,140
Accounts payable 137,911
Other Current Liabilities 98,850
Total Current Liabilities  (as reported)665,406
Total Current Liabilities  (calculated)646,901
+/- 18,505
Long-term Liabilities
Long term Debt 48,680
Capital Lease Obligations Min Short Term Debt44,337
Other Liabilities 18,290
Long-term Liabilities Other 1,025
Long-term Liabilities  (as reported)92,802
Long-term Liabilities  (calculated)112,332
+/- 19,530
Total Stockholder Equity
Common Stock306,820
Other Stockholders Equity -48,531
Total Stockholder Equity (as reported)258,289
Total Stockholder Equity (calculated)258,289
+/-0
Other
Capital Stock306,820
Common Stock Shares Outstanding 395,897
Net Debt 382,989
Net Invested Capital 717,109
Net Tangible Assets 199,656
Net Working Capital -179,410
Property Plant and Equipment Gross 628,212



Balance Sheet

Currency in HKD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
333,502
348,111
420,310
697,332
860,248
1,293,977
1,333,103
1,222,242
1,374,577
1,205,863
1,016,497
1,016,4971,205,8631,374,5771,222,2421,333,1031,293,977860,248697,332420,310348,111333,502
   > Total Current Assets 
0
240,214
305,606
541,172
658,520
692,185
732,224
597,702
607,678
610,857
485,996
485,996610,857607,678597,702732,224692,185658,520541,172305,606240,2140
       Cash And Cash Equivalents 
36,839
32,852
46,736
232,243
209,129
86,805
104,884
68,009
91,401
59,671
75,831
75,83159,67191,40168,009104,88486,805209,129232,24346,73632,85236,839
       Short-term Investments 
0
15,861
20,633
9,168
14,738
26,791
29,170
0
0
0
0
000029,17026,79114,7389,16820,63315,8610
       Net Receivables 
106,019
111,240
115,160
158,108
238,515
242,760
293,234
230,734
222,434
269,569
163,811
163,811269,569222,434230,734293,234242,760238,515158,108115,160111,240106,019
       Other Current Assets 
16,265
15,047
33,184
6,000
11,000
9,000
11,213
27,292
37,023
27,794
31,183
31,18327,79437,02327,29211,2139,00011,0006,00033,18415,04716,265
   > Long-term Assets 
0
0
0
0
201,728
601,792
600,879
624,540
766,899
595,006
530,501
530,501595,006766,899624,540600,879601,792201,7280000
       Property Plant Equipment 
71,827
80,694
77,729
93,713
117,383
297,059
294,676
360,473
459,352
461,015
431,077
431,077461,015459,352360,473294,676297,059117,38393,71377,72980,69471,827
       Goodwill 
0
0
0
0
0
155,685
155,685
88,339
88,339
20,993
20,993
20,99320,99388,33988,339155,685155,68500000
       Long Term Investments 
0
10,234
10,531
2,499
11,190
11,548
10,741
18,195
0
0
0
00018,19510,74111,54811,1902,49910,53110,2340
       Intangible Assets 
4,209
5,222
7,134
8,939
26,470
35,175
81,812
34,275
42,920
41,062
37,640
37,64041,06242,92034,27581,81235,17526,4708,9397,1345,2224,209
       Long-term Assets Other 
0
0
0
0
201,728
601,792
600,879
624,540
44,087
5,283
5,370
5,3705,28344,087624,540600,879601,792201,7280000
> Total Liabilities 
289,475
274,999
284,497
227,622
405,743
744,895
770,884
860,119
862,919
804,305
758,208
758,208804,305862,919860,119770,884744,895405,743227,622284,497274,999289,475
   > Total Current Liabilities 
286,806
268,440
282,575
225,952
402,760
684,094
600,725
639,080
591,887
665,314
665,406
665,406665,314591,887639,080600,725684,094402,760225,952282,575268,440286,806
       Short-term Debt 
0
188,190
182,692
125,431
261,048
493,744
376,232
327,282
279,329
172,456
0
0172,456279,329327,282376,232493,744261,048125,431182,692188,1900
       Short Long Term Debt 
0
188,190
182,692
125,431
261,048
493,744
376,232
327,282
279,329
407,671
410,140
410,140407,671279,329327,282376,232493,744261,048125,431182,692188,1900
       Accounts payable 
48,783
29,873
44,546
38,091
74,191
112,195
139,201
178,985
159,344
140,679
137,911
137,911140,679159,344178,985139,201112,19574,19138,09144,54629,87348,783
       Other Current Liabilities 
55,050
55,224
55,337
40,105
40,727
48,091
56,741
70,758
121,812
103,725
98,850
98,850103,725121,81270,75856,74148,09140,72740,10555,33755,22455,050
   > Long-term Liabilities 
0
0
0
0
2,983
60,801
170,159
221,039
271,032
138,991
92,802
92,802138,991271,032221,039170,15960,8012,9830000
       Long term Debt Total 
0
0
0
0
0
54,277
164,449
186,221
213,380
111,049
0
0111,049213,380186,221164,44954,27700000
       Capital Lease Obligations Min Short Term Debt
0
-188,190
-182,692
-125,431
-261,048
-493,744
-352,110
-256,746
-213,539
-140,165
44,337
44,337-140,165-213,539-256,746-352,110-493,744-261,048-125,431-182,692-188,1900
       Long-term Liabilities Other 
0
0
0
0
0
3,731
3,194
2,038
3,853
1,174
1,025
1,0251,1743,8532,0383,1943,73100000
> Total Stockholder Equity
43,974
73,032
135,689
469,710
454,505
549,082
562,219
362,123
511,658
401,558
258,289
258,289401,558511,658362,123562,219549,082454,505469,710135,68973,03243,974
   Common Stock
0
0
30,000
174,375
174,375
191,981
191,981
204,028
306,042
306,042
306,820
306,820306,042306,042204,028191,981191,981174,375174,37530,00000
   Retained Earnings 
40,885
67,149
81,680
105,385
137,547
136,814
155,747
-71,511
-40,319
-133,032
-282,263
-282,263-133,032-40,319-71,511155,747136,814137,547105,38581,68067,14940,885
   Capital Surplus 
0
0
0
170,552
150,616
206,672
206,811
224,484
220,658
221,189
0
0221,189220,658224,484206,811206,672150,616170,552000
   Treasury Stock00000000000
   Other Stockholders Equity 
0
5,883
4,077
24,965
-32,718
-13,692
-20,966
-23,524
-3,887
7,359
-48,531
-48,5317,359-3,887-23,524-20,966-13,692-32,71824,9654,0775,8830



Balance Sheet

Currency in HKD. All numbers in thousands.




Cash Flow

Currency in HKD. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue448,069
Cost of Revenue-185,365
Gross Profit262,704262,704
 
Operating Income (+$)
Gross Profit262,704
Operating Expense-492,345
Operating Income-44,276-229,641
 
Operating Expense (+$)
Research Development0
Selling General Administrative315,298
Selling And Marketing Expenses0
Operating Expense492,345315,298
 
Net Interest Income (+$)
Interest Income475
Interest Expense-24,183
Other Finance Cost-0
Net Interest Income-23,708
 
Pretax Income (+$)
Operating Income-44,276
Net Interest Income-23,708
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-119,182-44,276
EBIT - interestExpense = -120,244
-119,182
-96,031
Interest Expense24,183
Earnings Before Interest and Taxes (EBIT)-96,061-94,999
Earnings Before Interest and Taxes (EBITDA)-46,338
 
After tax Income (+$)
Income Before Tax-119,182
Tax Provision-1,032
Net Income From Continuing Ops-120,214-120,214
Net Income-120,214
Net Income Applicable To Common Shares-120,214
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses43,467
Total Other Income/Expenses Net023,708
 

Technical Analysis of Purapharm
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Purapharm. The general trend of Purapharm is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Purapharm's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Purapharm Corp Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.75 < 0.75 < 0.75.

The bearish price targets are: 0.73.

Tweet this
Purapharm Corp Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Purapharm Corp Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Purapharm Corp Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Purapharm Corp Ltd. The current macd is -0.01926485.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Purapharm price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Purapharm. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Purapharm price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Purapharm Corp Ltd Daily Moving Average Convergence/Divergence (MACD) ChartPurapharm Corp Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Purapharm Corp Ltd. The current adx is 14.58.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Purapharm shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Purapharm Corp Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Purapharm Corp Ltd. The current sar is 0.87462733.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Purapharm Corp Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Purapharm Corp Ltd. The current rsi is 39.78. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Purapharm Corp Ltd Daily Relative Strength Index (RSI) ChartPurapharm Corp Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Purapharm Corp Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Purapharm price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Purapharm Corp Ltd Daily Stochastic Oscillator ChartPurapharm Corp Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Purapharm Corp Ltd. The current cci is -117.17171717.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Purapharm Corp Ltd Daily Commodity Channel Index (CCI) ChartPurapharm Corp Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Purapharm Corp Ltd. The current cmo is -26.22585109.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Purapharm Corp Ltd Daily Chande Momentum Oscillator (CMO) ChartPurapharm Corp Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Purapharm Corp Ltd. The current willr is -90.90909091.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Purapharm Corp Ltd Daily Williams %R ChartPurapharm Corp Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Purapharm Corp Ltd.

Purapharm Corp Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Purapharm Corp Ltd. The current atr is 0.02989207.

Purapharm Corp Ltd Daily Average True Range (ATR) ChartPurapharm Corp Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Purapharm Corp Ltd. The current obv is 31,378,750.

Purapharm Corp Ltd Daily On-Balance Volume (OBV) ChartPurapharm Corp Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Purapharm Corp Ltd. The current mfi is 30.61.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Purapharm Corp Ltd Daily Money Flow Index (MFI) ChartPurapharm Corp Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Purapharm Corp Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Purapharm Corp Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Purapharm Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.777
Ma 20Greater thanMa 500.790
Ma 50Greater thanMa 1000.802
Ma 100Greater thanMa 2000.846
OpenGreater thanClose0.750
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Purapharm with someone you think should read this too:
  • Are you bullish or bearish on Purapharm? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Purapharm? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Purapharm Corp Ltd

I send you an email if I find something interesting about Purapharm Corp Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Purapharm Corp Ltd.

Receive notifications about Purapharm Corp Ltd in your mailbox!